szg3w0a3

Property	Value
?:abstract	AIM: The present review aimed to consolidate and analyze the recent information about the use of zebrafish in studies concerning cisplatin-induced ototoxicity and otoprotection. MATERIAL AND METHODS: The PubMed, Web of Science, and Scopus databanks were searched using the following MESH terms: zebrafish, cisplatin, ototoxicity. The identified publications were screened according to inclusion and exclusion criteria and the 26 qualifying manuscripts were included in the full-text analysis. The experimental protocols, including cisplatin concentrations, the exposure duration and the outcome measurements used in zebrafish larvae studies, were evaluated and the reported knowledge was summarized. RESULTS: Twenty-six substances protecting from cisplatin-induced toxicity were identified with the use of zebrafish larvae. These substances include quinine, salvianolic acid B, berbamine 6, benzamil, quercetin, dexmedetomidine, dexamethsanone, quinoxaline, edaravone, apocynin, dimethyl sulfoxide, KR-22335, SRT1720, ORC-13661, 3-MA, D-methionine, mdivi-1, FUT-175, rapamycin, Z-LLF-CHO, ATX, NAC, CYM-5478, CHCP1, CHCP2 and leupeptin. The otoprotective effects of compounds were attributed to their anti-ROS, anti-apoptotic and cisplatin uptake-blocking properties. The broadest range of protection was achieved when the experimental flow used preconditioning with an otoprotective compound and later a co-incubation with cisplatin. Protection against a high concentration of cisplatin was observed only in protocols using short exposure times (4 and 6 h). CONCLUSIONS: The data extracted from the selected papers confirm that despite the differences between the human and the zebra fish hearing thresholds (as affected by cisplatin), the sensory cells of zebrafish and larval zebrafish are a valuable tool which could be used: (i) for the discovery of novel otoprotective substances and compounds; (ii) to screen their side effects and (iii) to extend the knowledge on the mechanisms of cisplatin-induced inner ear damage. For future studies, the development of a consensus experimental protocol is highly recommended.
is ?:annotates of	<https://research.tib.eu/covid-19/entity/szg3w0a3_hasAnnotation_C0034437> <https://research.tib.eu/covid-19/entity/szg3w0a3_hasAnnotation_C0053142> <https://research.tib.eu/covid-19/entity/szg3w0a3_hasAnnotation_C0235280> <https://research.tib.eu/covid-19/entity/szg3w0a3_hasAnnotation_C0600688> <https://research.tib.eu/covid-19/entity/szg3w0a3_hasAnnotation_C1414408> <https://research.tib.eu/covid-19/entity/szg3w0a3_hasAnnotation_C1421537> <https://research.tib.eu/covid-19/entity/szg3w0a3_hasAnnotation_C1709820> <https://research.tib.eu/covid-19/entity/szg3w0a3_hasAnnotation_C2000799> <https://research.tib.eu/covid-19/entity/szg3w0a3_hasAnnotation_C3886616>
?:creator	<https://research.tib.eu/covid-19/entity/Domarecka%2C_Ewa%3B_Skarzynska%2C_Magda%3B_Szczepek%2C_Agnieszka_J%3B_Hatzopoulos%2C_Stavros>
?:journal	Int_J_Immunopathol_Pharmacol
?:license	unk
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/COVID-19>
is ?:relation_isRelatedTo_publication of	<https://research.tib.eu/covid-19/entity/szg3w0a3_HAS_C0008838_CAUSES_C0235280> <https://research.tib.eu/covid-19/entity/szg3w0a3_HAS_C0008838_CAUSES_C0600688>
?:source	WHO
?:title	Use of zebrafish larvae lateral line to study protection against cisplatin-induced ototoxicity: A scoping review
?:type	<https://research.tib.eu/covid-19/vocab/Publication>
?:who_covidence_id	#33084473
?:year	2020

Property

Value

?:abstract

AIM: The present review aimed to consolidate and analyze the recent information about the use of zebrafish in studies concerning cisplatin-induced ototoxicity and otoprotection. MATERIAL AND METHODS: The PubMed, Web of Science, and Scopus databanks were searched using the following MESH terms: zebrafish, cisplatin, ototoxicity. The identified publications were screened according to inclusion and exclusion criteria and the 26 qualifying manuscripts were included in the full-text analysis. The experimental protocols, including cisplatin concentrations, the exposure duration and the outcome measurements used in zebrafish larvae studies, were evaluated and the reported knowledge was summarized. RESULTS: Twenty-six substances protecting from cisplatin-induced toxicity were identified with the use of zebrafish larvae. These substances include quinine, salvianolic acid B, berbamine 6, benzamil, quercetin, dexmedetomidine, dexamethsanone, quinoxaline, edaravone, apocynin, dimethyl sulfoxide, KR-22335, SRT1720, ORC-13661, 3-MA, D-methionine, mdivi-1, FUT-175, rapamycin, Z-LLF-CHO, ATX, NAC, CYM-5478, CHCP1, CHCP2 and leupeptin. The otoprotective effects of compounds were attributed to their anti-ROS, anti-apoptotic and cisplatin uptake-blocking properties. The broadest range of protection was achieved when the experimental flow used preconditioning with an otoprotective compound and later a co-incubation with cisplatin. Protection against a high concentration of cisplatin was observed only in protocols using short exposure times (4 and 6 h). CONCLUSIONS: The data extracted from the selected papers confirm that despite the differences between the human and the zebra fish hearing thresholds (as affected by cisplatin), the sensory cells of zebrafish and larval zebrafish are a valuable tool which could be used: (i) for the discovery of novel otoprotective substances and compounds; (ii) to screen their side effects and (iii) to extend the knowledge on the mechanisms of cisplatin-induced inner ear damage. For future studies, the development of a consensus experimental protocol is highly recommended.

is ?:annotates of